The 2020 US presidential election looks set to stand the test of time as one of the most critical votes for the American people.

In addition to deciding the immediate future of the country, this election has many potential ramifications when it comes to the cannabis industry.

The fractured state of the US cannabis space has prevented a free-flowing market from flourishing, and has left policy and banking regulations on the back burner.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

The decision between four more years of Donald Trump or a new president in Joe Biden may determine the federal standing of cannabis, and there are state-by-state decisions on the docket as well.

While Biden has expressed concerns about cannabis and what he considers a lack of research geared at disproving commonly believed views on its effects, his running mate Kamala Harris has spoken positively about the drug. It is expected that if the Democrats takes the White House they will have a more favorable view on cannabis, its medical benefits and the business surrounding it.

For his part, Trump has been a mixed bag when it comes to cannabis. Jeff Sessions, his first appointed attorney general, mounted what seemed to be a campaign against the burgeoning industry at the state level. Sessions was later removed from his post, leaving a nebulous federal view on the drug.

Even so, cannabis has thrived in the US due to the development of state markets that have legalized medical or recreational cannabis sales. They have allowed the licensing of growing facilities and the development of novel regulated products like vape pens and edibles.

Thanks to the opening of these state markets, various companies have reached investors with the promise of modern commerce options with steady sales and widespread dispensary networks.

These companies have adopted the multi-state operator (MSO) moniker given that they must build operations from the ground up in each state they enter, whether it is via an acquisition or organically.

2020 has been good for MSOs, which have grown from being an alternative marijuana investment to the dominant type of cannabis company in the market — at least according to one financial expert.

“The US is a much bigger market, a much better market, and now this year the US market is performing a lot better than most of the Canadian market,” said Dan Ahrens, managing director and chief operating officer at AdvisorShares, and the active manager for the AdvisorShares Pure Cannabis ETF (ARCA:YOLO) and the AdvisorShares Pure US Cannabis ETF (ARCA:MSOS).

Cannabis investors will have to keep a close eye on the results of the US presidential election as it may signify a new era for the industry. Click through to the links below to read more:

Don’t forget to follow us @INN_Cannabis for real-time updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

US Election 2020 and Cannabis

Will Trump or Biden win the fast-approaching US presidential election? And which candidate would be better...

What Happens to Cannabis if Trump Wins?

INN checked in with experts in the industry to investigate the path the cannabis business may...

What Happens to Cannabis if Biden Wins?

INN checked in with experts in the industry to investigate how the cannabis business could change...

Which States are Voting on Cannabis in...

As the US cannabis market develops, these five states are inching closer to legalizing the drug...


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness Company offering premium probiotic supplements and products containing CBD, announces that it has promoted Maria Leal, the Company’s Vice President and Controller, to Interim Chief Financial Officer.

Ms. Leal holds a CPA and an MBA and has a strong track record in financial management having served in various senior financial accounting positions during her more than 20-year career. Ms. Leal has been with HempFusion since July 2019 and has been instrumental in all financial reporting aspects for the Company.

Keep reading... Show less

Centurion to acquire a Disruptive Water-Soluble Cannabinoid Technology Platform Delivering Rapid Onset, Increased Bioavailability, Premium Taste Profiles and Highly Competitive Cost Structure

Centurion Minerals Ltd. (TSXV: CTN) (“Centurion”, or the “Company”) wishes to provide an update on its previously announced Amalgamation Agreement (the “Agreement”), with HAI Beverages Inc. (“HAI”), whereby Centurion is acquiring 100% of the outstanding shares and assets of a wholly-owned subsidiary of HAI (“NewHAI”) in exchange for common shares of Centurion (the “Acquisition” or “Transaction”). NewHAI holds all material assets of HAI and the Acquisition will constitute a reverse take-over (“RTO”) of the Company.

Keep reading... Show less

Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, is pleased to announce that it has received approval to graduate  to Tier 1 Issuer status on the TSX Venture Exchange (the “TSXV”), effective June 18, 2021 .

Keep reading... Show less

Harvest Health & Recreation Inc. (“Harvest”) ( CSE: HARV OTCQX: HRVSF ), a vertically integrated cannabis company and multi-state operator in the U.S., today announced the opening of two new medical dispensaries in Lehigh Acres and North Miami Beach, Florida .

Harvest of Lehigh Acres is located at 1315 Homestead Road N Ste B, Lehigh Acres .
Harvest of North Miami Beach is located at 15100 Biscayne Blvd, North Miami Beach .
Both locations are open Monday through Saturday from 9:00 am to 8:00 pm and Sunday from 10:00 am to 7:00 pm .

Keep reading... Show less

Canbud Distribution Corp. (CSE: CBDX) (“Canbud” or the “Corporation”) is pleased to announce that, further to its news release of May 27, 2021, it has entered into a definitive acquisition agreement (the “Acquisition Agreement”) with Molecular Science Corp. (“MSC”) and 2847719 Ontario Inc. (“Subco”), a wholly-owned subsidiary of Canbud, pursuant to which it agreed to acquire all of the outstanding securities of MSC by way of a three-cornered amalgamation (the “Transaction”). The Transaction is subject to receipt of all necessary regulatory approvals, including, as applicable, approval of the Canadian Securities Exchange (“CSE”), and certain other conditions as described below.

About MSC

Keep reading... Show less